Clinical trials recruiting in Quint-Fonsegrives, France

Phase breakdown

Conditions recruiting in Quint-Fonsegrives, France

Recruiting trials in Quint-Fonsegrives, France

• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
  NCT06136650 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
  NCT05973864 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
  NCT07237256 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female
• Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU
  NCT06945172 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 75 Years · Sex: Male
• Cost-utility of Focal HIFU vs Prostatectomy
  NCT05710861 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 75 Years · Sex: Male
• Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO)
  NCT07469007 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 39 Years · Sex: Female
• Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
  NCT05974774 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: Male
• PRostate Olaparib Real World Evidence Study
  NCT06031805 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC
  NCT06078384 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Quint-Fonsegrives, France?

10 recruiting trials have at least one study site in Quint-Fonsegrives, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.